Medibank, AU000000MPL3

Medibank stock gained 0.44 percent as FY26 health profit rose

Published on 10/05/2026 at 12:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medibank stock rose 0.44 percent to AUD 4.530 on October 2, 2026, while FY26 health revenue reached AUD 634.8 million. Analysts set a Hold consensus.

Medibank, AU000000MPL3, Illustration mit AI erstellt.
Medibank, AU000000MPL3, Illustration mit AI erstellt.

Medibank (ISIN AU000000MPL3) was last at AUD 4.530 on the ASX on October 2, 2026, up 0.44 percent on the session. The latest full-year picture shows a sharper growth engine outside traditional insurance, with health services revenue reaching AUD 634.8 million in fiscal year 2026.

Health services drives growth

According to Medical Republic on September 16, 2026, Medibank Health revenue increased 31 percent to AUD 634.8 million in FY26. Primary care revenue rose 29.6 percent to AUD 316.5 million, while the network expanded to 169 clinics.

The segment profit comparison is equally important: Medibank Health profit increased 31.3 percent to AUD 100.7 million in FY26, including AUD 6.2 million from Better Medical. Operating profit rose 27.4 percent to AUD 107.3 million, according to Medical Republic.

Insurance remains the earnings base

The core insurance division generated AUD 8.59 billion of revenue in FY26, up 4.6 percent, while operating profit increased 3.8 percent to AUD 769.8 million. That contrast makes the growth mix central to the investment case: healthcare services expanded at double-digit rates, while insurance delivered steadier progress.

Cost pressures remain visible in the outlook. Medibank reported a 150-basis-point Revenue Mix impact in FY26 and expected the impact in FY27 to be similar, while a AUD 74.8 million COVID utilization benefit recorded in FY26 will not recur, according to Medical Republic.

Consensus stays at Hold

The analyst picture is more measured than the health-services growth rate. Stock Analysis lists a Hold consensus from 9 analysts and an average price target of AUD 5.00, which is 10.38 percent above the October 2 price of AUD 4.530.

Shareholder income is the next dated checkpoint. Simply Wall St lists a fully franked AUD 0.109 dividend for the six months ended June 30, 2026, with payment scheduled for October 8, 2026.

Medibank stock holds at AUD 4.530

Medibank stock had a market capitalization of AUD 12.48 billion as of October 2, 2026. The ASX quote stood at AUD 4.530 at 4:10 p.m. AEST, giving investors a dated market value alongside the FY26 operating comparison.

Medibank stock details

  • Company: Medibank Private Limited
  • ISIN: AU000000MPL3
  • Ticker: MPL.AX
  • Trading venue: ASX
  • Price (as of October 2, 2026, 4:10 p.m. AEST): AUD 4.530
  • Market capitalization: AUD 12.48 billion (as of October 2, 2026)
  • Sector / Industry: Financials / Life and Health Insurance

Upcoming dates for Medibank stock

  • October 8, 2026: Payment of the fully franked dividend

More news and analysis on Medibank stock

Disclaimer...

en | AU000000MPL3 | MEDIBANK | boerse | 70232099 | bgmi